Governed multi-omics discovery for therapeutic and diagnostic target prioritization.
E-DICE-R adds a governance layer to AI systems and is now being applied to multi-omics discovery, biomarker workflows, and other high-risk decision environments.
How to get started
Three simple steps to explore the platform, review our research, and request access.
Read the platform overview, research findings, and team page to understand what E-DICE-R does.
Platform Overview →Sign up to access the investor brochure, API documentation, and the full onboarding portal.
Create Account →Download the investor brochure or contact the team directly to discuss a pilot engagement.
View Pricing →Built for partners who need governed discovery at scale.
A live platform, an active discovery program, and a clear collaboration path for investors, research partners, and enterprise teams.
A first-mover position in authority-governed AI for biomedical discovery — live infrastructure, peer-reviewed publication, and a clear path to pharma and research engagement.
Governed biomarker and target discovery workflows with structured validation paths, federated data collaboration, and reproducible computational outputs.
Deploy a governance control layer alongside existing AI systems. Prevent unsafe automation, enforce policies, and reduce unintended outcomes in high-stakes workflows.
PRR36 — surfaced from 19,010 genes.
E-DICE-R screened the full TCGA prostate cancer dataset under governed controls and surfaced a statistically strong signal with no prior cancer publications found at the time of review.
Transcriptomics · Genomics · Survival · Reproducibility · Literature · Druggability — all six evidence types evaluated under full governance controls.
Running cancer biomarker workflows right now.
E-DICE-R is being applied to cancer biomarker discovery and multi-omics analysis in a live cloud workflow.
The current focus is stable, reproducible signal discovery, with broader research workflows to follow.
Focused on stable and reproducible signals.
E-DICE-R helps teams focus on the signals that are strong enough to take seriously in complex research workflows.
Research data is prepared for structured multi-omics exploration and review.
E-DICE-R adds a control layer before actions move forward in the workflow.
Teams review biomarker and pathway candidates with more confidence and less noise.
The current phase is focused on discovery, validation, and repeatable review.
The platform now shows both the people and the discovery momentum.
The site now highlights both the interdisciplinary team and the current discovery work in a simpler, public-safe way.
Meet the team
View the advisors, scientific contributors, and builders supporting governed AI, biology, mathematics, clinical review, and product delivery.
Open team pageCurrent discovery work
Read the summarized early discovery signal from our multi-omics workflow, written carefully for public-facing review and future validation updates.
Read discovery summaryAI is moving from answering to acting.
Without control, systems can trigger actions that teams did not intend to approve.
High risk environments need a layer that evaluates decisions before execution.
Organizations need a way to keep actions aligned with boundaries and oversight.
Complex biomedical workflows need help filtering results before downstream use.
E-DICE-R sits between AI output and execution.
It gives organizations a cleaner way to review, allow, block, or constrain actions before they move forward. This is especially important in healthcare, infrastructure, enterprise systems, and other high consequence environments.
We control what AI is allowed to do.
A simple control layer for existing systems.
E-DICE-R works alongside existing AI systems and research workflows. It does not replace them. It adds a review and control layer before execution.
Built for environments where incorrect decisions have real consequences.
E-DICE-R helps evaluate actions before execution. It gives organizations a way to add control, reduce unintended outcomes, and operate with more confidence.
- Evaluate actions before they run
- Prevent unsafe or unauthorized behavior
- Enable controlled automation
- Runs alongside existing systems
- Designed for high risk domains
E-DICE-R runs the research workflow from dataset preparation through candidate discovery so teams can explore biomarkers and review findings with more structure.
- Multi-omics research workflows
- Biomarker discovery and validation
- Review-ready candidate outputs
- Supports early collaborator programs
- Built for live testing and iteration
E-DICE combines artificial intelligence and quantum-inspired optimization to support smarter enterprise decisions, customer service, and operational workflows.
- Next-gen decision intelligence positioning
- Designed for enterprise workflows and routing
- Built around speed, security, and reliability goals
- Aligned with research and industry collaboration
- Connects to Infinity Software Architects direction
Pilot pricing for early collaborators.
Start with a fixed-scope pilot. Move to a subscription once the workflow proves value.
Best for first engagement and proof of value.
- Dataset onboarding
- Governed multi-omics analysis
- Candidate output review
- Review session with findings
- Final report with replayable results
For discovery teams validating governed candidate selection across broader research programs.
- Multiple governed runs
- Biomarker and pathway candidate ranking
- Cross-cohort consistency analysis
- Team review and pilot summary
- Suitable for experimental collaborations
For larger exploratory programs and translational research teams.
- Custom workflow design
- Collaborative validation support
- Replayable outputs and reporting
- Executive readout and roadmap
- Designed for larger research teams
Limited governed runs for small research teams.
Full governed pipelines for active discovery programs.
Custom workflows, higher-touch support, and broader integration.
Where control is not optional.
Prevent unsafe automation and add control before workflows move forward.
Restrict tool usage and reduce unintended or unauthorized actions.
Support recommendations while keeping a clear review layer for high risk research workflows.
Control system level changes and reduce the risk of cascading failures.
Request the E-DICE-R brief.
Use this secure entry point to request access, review onboarding materials, and move approved users into the protected API access experience.
- Signed-in access to Swagger documentation
- API keys and usage limits for approved users
- Protected onboarding path for brochure and developer access
What comes next
- Customer onboarding guide portal
- Customer login and guided demo access
- Physician form and validator-facing workflows
- Further refinement for commercial rollout
Built to be clear, credible, and sale-ready.
Validation status
- Architecture: Complete
- Adversarial and simulation testing: Complete
- Multi-omics dataset testing: In progress
- External validation: In development
What clients are buying
- Reduced false candidates
- Better focus of validation effort
- More confidence before downstream use
- Replayable analysis outputs and review-ready reporting
Research. Product. Execution.
E-DICE-R
E-DICE-R focuses on governed multi-omics research, ranked target discovery, and reproducible execution under authority-based controls.
- E-DICE research directionBiomarker discovery, validation, and future patient-level analysis
- High risk domain focusHealthcare, infrastructure, enterprise systems, and AI agent workflows
Infinity Software Architects, Inc.
Infinity Software Architects is positioned around next-generation AI and quantum-inspired optimization for smarter enterprise decisions. The broader direction combines research, enterprise workflows, and customer service applications.
- Enterprise directionDecision intelligence, routing, and operational workflows
- Industry and research alignmentBuilt alongside research collaboration and enterprise-facing positioning
Talk to the team and request access.
Phone
Headquarters
Infinity Software Architects, Inc
Quantum Bridge Capital, LLC
Address
4781 N. Congress Ave. #165,
Boynton Beach, FL 33462
Interested in early access?
Review the pricing, request the brochure, or explore the broader product experience through the portal, login, physician form, and workflow interfaces.